M H Yu
Impact in
-
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Glycosylation and Glycoproteins Research 2
- Oncology 4
- Co-authors
- Steve R. Roffler (4 shared papers)M Y Yeh (4 shared papers)Tang‐Yuan Chu (3 shared papers)Chun‐Chi Chen (1 shared paper)M.S. Kao (1 shared paper)Cheng‐Chang Chang (1 shared paper)Ching‐Yu Lin (1 shared paper)Bing‐Mae Chen (1 shared paper)
- Journals
- International Journal of Gynecological Cancer (3 papers)International Journal of Gynecology & Obstetrics (2 papers)Gynecologic Oncology (1 paper)Histochemistry and Cell Biology (1 paper)Biotechnology Letters (1 paper)
- Partner nations
- TaiwanNew ZealandSouth Korea
In The Last Decade
M H Yu
15 papers receiving 112 citations
Peers
Comparison fields: 5 of 39
- Obstetrics and Gynecology 28
- Toxicology 6
- Reproductive Medicine 14
- Spectroscopy 13
- Immunology 15
Countries citing papers authored by M H Yu
This map shows the geographic impact of M H Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M H Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M H Yu more than expected).
Fields of papers citing papers by M H Yu
This network shows the impact of papers produced by M H Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M H Yu. The network helps show where M H Yu may publish in the future.
Co-authors
The 20 scholars most cited alongside M H Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 21 | |
| 2 | 2000 | 15 | |
| 3 | Therapy of human cervical carcinoma with monoclonal antibody-Pseudomonas exotoxin conjugates. | 1991 | 15 |
| 4 | 2006 | 11 | |
| 5 | 1995 | 10 | |
| 6 | 2005 | 9 | |
| 7 | Chemotherapy with low-dose bevacizumab and carboplatin in the treatment of a patient with recurrent cervical cancer. | 2010 | 8 |
| 8 | 2002 | 8 | |
| 9 | New monoclonal antibody against human cervical carcinoma with diagnostic and therapeutic potential. | 1991 | 6 |
| 10 | Verrucous carcinoma of the uterine cervix. | 2000 | 4 |
| 11 | 1998 | 2 | |
| 12 | Prognostic role of MUC-2 expression in patients with gastric carcinoma: a systematic review and meta-analysis | 2021 | 1 |
| 13 | Effects of temperature on radiochemical purity and immunoreactivity of radiolabeled monoclonal antibody 1H10. | 2000 | 1 |
| 14 | 1992 | 1 | |
| 15 | 1997 | 1 |
About M H Yu
M H Yu is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Obstetrics and Gynecology and Immunology, having authored 15 papers that have together received 113 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), Advanced Proteomics Techniques and Applications (2 papers), Glycosylation and Glycoproteins Research (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Vitamin C and Antioxidants Research (1 paper), Endometriosis Research and Treatment (1 paper), Galectins and Cancer Biology (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Obstetrics and Gynecology (28 citations), Toxicology (6 citations), Reproductive Medicine (14 citations), Spectroscopy (13 citations) and Immunology (15 citations). M H Yu has collaborated with scholars based in Taiwan, New Zealand and South Korea. Frequent co-authors include Steve R. Roffler, M Y Yeh, Tang‐Yuan Chu, Chun‐Chi Chen, M.S. Kao, Cheng‐Chang Chang, Ching‐Yu Lin, Bing‐Mae Chen, Ya‐Wen Lin and Chia‐Chen Chang. Their work appears in journals such as International Journal of Gynecological Cancer, International Journal of Gynecology & Obstetrics, Gynecologic Oncology, Histochemistry and Cell Biology and Biotechnology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.